We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
+9.73%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+545.54%
AUM
$492B
AUM Growth
+$21.5B
Cap. Flow
-$23.6B
Cap. Flow %
-4.79%
Top 10 Hldgs %
30.05%
Holding
13,811
New
1,371
Increased
4,862
Reduced
5,559
Closed
1,866

Sector Composition

Rank Sector Weight
1 Technology 2.7%
2 Consumer Discretionary 1.66%
3 Financials 1.18%
4 Communication Services 1.07%
5 Healthcare 0.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TLIS
11776
DELISTED
Talis Biomedical Corporation Common Stock
TLIS
$5.03K ﹤0.01%
+698
New +$5.07K
FEXDR
11777
DELISTED
Fintech Ecosystem Development Corp. Right
FEXDR
$5.01K ﹤0.01%
45,236
-13,702
-23% -$1.7K
ISUN
11778
DELISTED
iSun, Inc. Common Stock
ISUN
$4.99K ﹤0.01%
12,465
-2,701
-18% -$1.62K
IGC icon
11779
PUT
IGC Pharma
IGC
$31.8M
$4.96K ﹤0.01%
16,000
TDW.WS.B
11780
DELISTED
Tidewater Inc. Series B Warrants to purchase shares of common stock (expiring July 31, 2023)
TDW.WS.B
$4.67K ﹤0.01%
+23,323
New +$5.76K
AEMD icon
11781
Aethlon Medical
AEMD
$1.62M
$4.65K ﹤0.01%
+3
New +$4.39K
KRRO icon
11782
CALL
Korro Bio
KRRO
$201M
$4.45K ﹤0.01%
254
-350
-58% -$6.79K
ESLAW icon
11783
Estrella Immunopharma Warrant
ESLAW
$172K
$4.35K ﹤0.01%
78,381
+54,010
+222% +$3.69K
AIMAW
11784
DELISTED
Aimfinity Investment Corp I Warrant
AIMAW
$4.29K ﹤0.01%
98,710
+4,276
+5% +$219
HGASW
11785
DELISTED
Global Gas Corporation Warrant
HGASW
$4.28K ﹤0.01%
101,108
-12,818
-11% -$496
QOMOR
11786
DELISTED
Qomolangma Acquisition Corp. Right
QOMOR
$4.2K ﹤0.01%
+29,986
New +$4.42K
KRRO icon
11787
Korro Bio
KRRO
$201M
$4.15K ﹤0.01%
240
-1,906
-89% -$37K
VIEW
11788
CALL
DELISTED
View, Inc. Class A Common Stock
VIEW
$4K ﹤0.01%
555
-963
-63% -$14.5K
AEVAW
11789
DELISTED
Aeva Technologies Warrants
AEVAW
$3.89K ﹤0.01%
+32,065
New +$3.76K
GFGDW
11790
DELISTED
The Growth for Good Acquisition Corporation Warrant
GFGDW
$3.76K ﹤0.01%
46,924
-15,555
-25% -$882
UAMY icon
11791
CALL
United States Antimony
UAMY
$757M
$3.66K ﹤0.01%
11,800
-8,600
-42% -$2.96K
INTEW
11792
DELISTED
Integral Acquisition Corporation 1 Warrants
INTEW
$3.31K ﹤0.01%
+36,819
New +$1.94K
APLMW icon
11793
Apollomics Inc Warrant
APLMW
$1.29M
$3.15K ﹤0.01%
37,008
+16,693
+82% +$1.49K
EBET
11794
DELISTED
EBET, INC. Common Stock
EBET
$3.13K ﹤0.01%
883
-384
-30% -$3.17K
ARBEW icon
11795
Arbe Robotics Warrant
ARBEW
$231K
$3.11K ﹤0.01%
+11,966
New +$3.05K
MOBQW
11796
DELISTED
Mobiquity Technologies, Inc. Warrant
MOBQW
$3.1K ﹤0.01%
+137,822
New +$4.91K
VBIO
11797
Valion Bio
VBIO
$648K
$3.09K ﹤0.01%
17
+9
+113% +$1.93K
NEXI
11798
DELISTED
NexImmune, Inc. Common Stock
NEXI
$3.07K ﹤0.01%
+441
New +$3.8K
BNIXW
11799
DELISTED
Bannix Acquisition Corp. Warrant
BNIXW
$3K ﹤0.01%
74,898
-8,339
-10% -$321
GDNRW
11800
DELISTED
Gardiner Healthcare Acquisitions Corp. Warrant
GDNRW
$2.97K ﹤0.01%
42,385
-2,716
-6% -$238

Similar funds

Jeff Yass's Q2 2023 Portfolio in Review

As of Q2 2023, Jeff Yass held 13,811 positions worth $492B, up 4.6% from $470B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Jeff Yass withdrew a net $23.6B in Q2 2023, closing 1,866 positions and reducing 5,559 holdings. Its most notable exit was Vanguard Intermediate-Term Corporate Bond ETF, an estimated $45.5M position sold in full.

By sector, the portfolio is most concentrated in Technology at 2.7% of assets, up from 2.3% a quarter earlier, followed by Consumer Discretionary and Financials.

Against the trend, Jeff Yass opened a new position in State Street SPDR Portfolio Aggregate Bond ETF worth $32.9M.

  • Jeff Yass's largest Q2 2023 buy was State Street SPDR Portfolio Aggregate Bond ETF: 1,297,445 shares worth $32.9M.
  • Jeff Yass added most to NVIDIA in Q2 2023, an estimated $1.79B increase.
  • Jeff Yass's biggest Q2 2023 reduction was Invesco QQQ Trust, cutting an estimated $2.48B.
  • Jeff Yass fully exited Vanguard Intermediate-Term Corporate Bond ETF in Q2 2023, selling an estimated $45.5M.
  • Jeff Yass's ten largest holdings make up 30% of its $492B portfolio in Q2 2023.
  • Jeff Yass opened 1,371 new positions and closed 1,866 in Q2 2023.
  • Jeff Yass's portfolio value rose 4.6% quarter-over-quarter to $492B.

Based on Susquehanna International Group's 13F filing for Q2 2023, filed 11 Aug 2023.